Conferences

featured article image

How the Post-COVID ASH Conference 2022 Provided a Platform to Nourish the Human Spirit with Work, Play, and Friendship

author

Hardeep Singh Phull, MD

Read Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Link to Stephen Douglas Smith, MD's page

Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Stephen Douglas Smith, MD

Dec 19, 2022 Link to Mantle Cell Lymphoma at ASH 2022 – More Answers, and More Questions

Read Benefits of Virtual Conference Attendance: ASH 2022 Edition

Link to Samuel Kareff, MD MPH's page

Benefits of Virtual Conference Attendance: ASH 2022 Edition

Samuel Kareff, MD MPH

Dec 19, 2022 Link to Benefits of Virtual Conference Attendance: ASH 2022 Edition

Read Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Link to Hayder Saeed, MD's page

Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Hayder Saeed, MD

Dec 19, 2022 Link to Are We Ready for a Newer Cellular Therapy Approach in Mature T Cell Lymphoma?

Read Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Link to Suzanne Baga, MA, RRT's page

Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Suzanne Baga, MA, RRT

Dec 19, 2022 Link to Interview with SABCS 2022 Co-Director Dr. Virginia Kaklamani

Read Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Heather Moore, CPP, PharmD and 1 other

Dec 19, 2022 Link to Advances in the Treatment of Hormone Receptor Positive and HER-2 Positive Breast Cancer

Read HER2-Low, A Separate Entity?

Link to David Rimm MD-PhD's page

HER2-Low, A Separate Entity?

David Rimm MD-PhD

Dec 18, 2022 Link to HER2-Low, A Separate Entity?

Read Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Link to Katharine Yao, MD's page

Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Katharine Yao, MD

Dec 18, 2022 Link to Contralateral Breast Cancer in Breast Cancer Patients with Germline Mutations

Read HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Link to Kalliopi Siziopikou, MD PhD's page

HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Kalliopi Siziopikou, MD PhD

Dec 18, 2022 Link to HER2 Low Breast Cancer: Pathology Issues for Accurate HER2 testing

Read Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Link to Kimberly J. Van Zee, MS, MD, FACS's page

Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Kimberly J. Van Zee, MS, MD, FACS

Dec 18, 2022 Link to Predicting Risk of Recurrence for DCIS: Do Commercially Available Genomic Assays Have Proven Added Value Over and Above the MSKCC DCIS Nomogram? And if Not, Why Should We Pay For Them?

Read AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease

Link to Jordan Axelrad, MD, MPH's page

AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease

Jordan Axelrad, MD, MPH

Dec 11, 2022 Link to AIBD 2022: Cancer in Patients With Inflammatory Bowel Disease

Read A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)

Link to Alan Colm Moss, MD FACG, AGAF, FEBG, FRCPI's page

A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)

Alan Colm Moss, MD FACG, AGAF, FEBG, FRCPI

Dec 11, 2022 Link to A Holistic View of Assessing Disease Severity in Inflammatory Bowel Disease (IBD)

Read Steroids: Never or Forever

Link to Raymond Keith Cross Jr., MD MS, AGAF, FACG's page

Steroids: Never or Forever

Raymond Keith Cross Jr., MD MS, AGAF, FACG

Dec 11, 2022 Link to Steroids: Never or Forever

Read ASH 2022: Sickle Cell Disease in the Big Easy

ASH 2022: Sickle Cell Disease in the Big Easy

Seethal A. Jacob, MD MS and 1 other

Dec 5, 2022 Link to ASH 2022: Sickle Cell Disease in the Big Easy

Read RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?

Link to Douglas Katz, MD's page

RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?

Douglas Katz, MD

Dec 5, 2022 Link to RSNA 2022 Annual Meeting: Three Years Later To Live in the Flesh in Chicago, or Teleportation via a Time Warp?

Read ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease

Link to Burton Eliot Appel, MD ,MBA's page

ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease

Burton Eliot Appel, MD ,MBA

Dec 5, 2022 Link to ASH 2022 Preview of an Education Session: Reproductive and Sexual Health in Sickle Cell Disease

Read Preview of The 64th American Society of Hematology Annual Meeting

Link to Reshma Ramlal, MD FACP's page

Preview of The 64th American Society of Hematology Annual Meeting

Reshma Ramlal, MD FACP

Dec 5, 2022 Link to Preview of The 64th American Society of Hematology Annual Meeting

Read Attending My 30th RSNA Annual Meeting

Link to C. Douglas Phillips, MD FACR's page

Attending My 30th RSNA Annual Meeting

C. Douglas Phillips, MD FACR

Dec 5, 2022 Link to Attending My 30th RSNA Annual Meeting

Read ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive Caplacizumab

Link to Camila Masias, MD's page

ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive Caplacizumab

Camila Masias, MD

Dec 5, 2022 Link to ASH 22 Presentation Preview: Most/All Patients With Acquired (Immune) Thrombotic Thrombocytopenic Purpura Receive Caplacizumab

Read ASH 2022 Preview: Perspectives of Black Patients and Hematologists About Increasing Enrollment of Black Americans in Clinical Trials

Link to Shakira J. Grant, MD's page

ASH 2022 Preview: Perspectives of Black Patients and Hematologists About Increasing Enrollment of Black Americans in Clinical Trials

Shakira J. Grant, MD

Dec 5, 2022 Link to ASH 2022 Preview: Perspectives of Black Patients and Hematologists About Increasing Enrollment of Black Americans in Clinical Trials

Read ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple Myeloma

Link to Marc Braunstein, MD PhD FACP's page

ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple Myeloma

Marc Braunstein, MD PhD FACP

Dec 1, 2022 Link to ASH 2022 Abstract Previews: Novel Immunotherapies for Multiple Myeloma

Read Eye on the Immune System: The ACAAI Annual Meeting Explores Management of Compromised Immunity

Link to Basil Michael Kahwash, MD's page

Eye on the Immune System: The ACAAI Annual Meeting Explores Management of Compromised Immunity

Basil Michael Kahwash, MD

Nov 21, 2022 Link to Eye on the Immune System: The ACAAI Annual Meeting Explores Management of Compromised Immunity